Advent Life Sciences
Overview
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA.
Investment Focus
- Innovative life sciences companies with strong management teams
- Potential for significant impact on patient care
- Alignment with Advent Life Sciences' strategic focus areas
Portfolio Companies
Reach Advent Life Sciences directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Advent Life Sciences
What sectors does Advent Life Sciences invest in?
Advent Life Sciences invests in Healthcare Services, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in England, United Kingdom. Advent Life Sciences is listed as a venture capital in the ConnectSafely investor database.
What stage does Advent Life Sciences invest at?
Advent Life Sciences backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Advent Life Sciences invest in?
Advent Life Sciences invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at Advent Life Sciences?
Team members listed for Advent Life Sciences include Satish Jindal (General Partner).
What companies has Advent Life Sciences invested in?
Advent Life Sciences's portfolio includes Glycomine, KaNDy Therapeutics and Nalu Medical.
How do I contact Advent Life Sciences?
Advent Life Sciences's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
